Therapeutic Asset Ratings
1,133 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
sz1003
Hepatocellular Carcinoma
Guangdong ProCapZoom Biosciences Co., Ltd.
Early P1
NR
()
Th-Cart-027
Neoplasm
Shanghai Tongji Hospital, Tongji University School of Medicine
Early P1
NR
()
Vgo-Cs01P
T-Cell Acute Lymphoblastic Leukemia
Shanghai Jiao Tong University School of Medicine
Early P1
NR
()
wl276 car-t cells
Glioblastoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
Early P1
NR
()
wtx212a
Neoplasm
Zhejiang University
Early P1
NR
()
XTYW007
Metabolic Dysfunction-Associated Steatotic Liver Disease
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Early P1
NR
()
Yolt-204
Hemoglobinopathy
Guangzhou Women and Children's Medical Center
Early P1
NR
()
yy2201
Cancer
Jiangsu YaYao Biotechnology Co., Ltd.
Early P1
NR
()
Showing 1126 to 1133 of 1,133 assets
Previous
Page 46 of 46
Next
